Charles River Laboratories | 市值

股票价格
173.66
每天变化
-4.95 -2.77%
每月一次
-13.87%
每年
5.69%
Q1 预测
173.03


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.89B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
USD 43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


市值 更改 日
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Cardinal Health USD 48.83B 11.54B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cigna USD 73.52B 3.42B 2025-12
Concord Medical Services Hldg CNY 59.92M 11.29M 2023-06
CVS Health USD 100.74B 5.12B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
Elevance Health USD 77.91B 5.15B 2025-12
Galapagos EUR 1.89B 49.73M 2026-03
Hologic USD 16.62B 1.67B 2025-12
Humana USD 30.81B 485M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Incyte USD 19.39B 2.83B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 101.25B 5.15B 2025-12
Merck EUR 47.59B 239.13M 2025-09
Mettler Toledo International USD 28.48B 3.19B 2025-12
Novartis USD 265.66B 9.48B 2025-09
Pfizer USD 141.57B 6.48B 2025-12
Quest Diagnostics USD 19.3B 2.01B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
UnitedHealth USD 299.03B 14.21B 2025-12
Veradigm USD 1.69B 34M 2022-09
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 19.8B 932M 2025-12


Charles River Laboratories 市值 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.